Thrombotic thrombocytopenic purpura (TTP) Centenary – a series of live webinars by Takeda

Thrombotic thrombocytopenic purpura (TTP) is a haematological and critical care emergency, with a 90% mortality rate if left untreated. The severity of TTP varies, and no consensual definition of severe TTP exists. Many patients with TTP require ICU admission, either due to severe organ failure or because the ICU is the only place in the hospital where PEX can be performed, a central line is inserted, and close monitoring is provided around the clock. Close monitoring is crucial, as sudden death can occur at any time during the first days of treatment, chiefly from cardiac microvasculature occlusion, arrhythmia, or cardiogenic shock. In a retrospective study of thrombotic microangiopathy (TMA) comparing survivors and nonsurvivors, the main factors associated with death were the absence of PEX and cardiac involvement.
Celebrating the TTP centenary is be a unique opportunity to improve the management skills of a wide range of healthcare professionals managing TTP patients, from those facing diagnostic challenges to TTP specialists managing acute TTP disease and relapses, or longer-term outcomes.
This 6-hour multi-disciplinary and interprofessional TTP-skills training programme comprises five 1h15 webinars. This series of online live webinars offers flexibility, allowing participants from various disciplines, countries, and time zones to access the content at their own pace and convenience. Additionally, it provides a diverse range of multimedia resources, fostering a dynamic learning environment that accommodates different learning styles, making it an effective means of knowledge transfer for a multidisciplinary audience. The programme will include worldwide specialists whose scientific contribution has reshaped TTP management and outcomes.
Thanks to the support of